<?xml version="1.0" encoding="UTF-8"?>
<ref id="B161-pharmaceuticals-12-00157">
 <label>161.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Adolf-Bryfogle</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kalyuzhniy</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Kubitz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Weitzner</surname>
    <given-names>B.D.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Adachi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Schief</surname>
    <given-names>W.R.</given-names>
   </name>
   <name>
    <surname>Dunbrack</surname>
    <given-names>R.L.</given-names>
    <suffix>Jr.</suffix>
   </name>
  </person-group>
  <article-title>RosettaAntibodyDesign (RAbD): A general framework for computational antibody design</article-title>
  <source>PLoS Comput. Biol.</source>
  <year>2018</year>
  <volume>14</volume>
  <elocation-id>e1006112</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pcbi.1006112</pub-id>
  <pub-id pub-id-type="pmid">29702641</pub-id>
 </element-citation>
</ref>
